We apologize for Proteopedia being slow to respond. For the past two years, a new implementation of Proteopedia has been being built. Soon, it will replace this 18-year old system. All existing content will be moved to the new system at a date that will be announced here.

1hnn

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
[[Image:1hnn.jpg|left|200px]]
+
{{Seed}}
 +
[[Image:1hnn.png|left|200px]]
<!--
<!--
Line 9: Line 10:
{{STRUCTURE_1hnn| PDB=1hnn | SCENE= }}
{{STRUCTURE_1hnn| PDB=1hnn | SCENE= }}
-
'''CRYSTAL STRUCTURE OF HUMAN PNMT COMPLEXED WITH SK&F 29661 AND ADOHCY(SAH)'''
+
===CRYSTAL STRUCTURE OF HUMAN PNMT COMPLEXED WITH SK&F 29661 AND ADOHCY(SAH)===
-
==Overview==
+
<!--
-
BACKGROUND: Adrenaline is localized to specific regions of the central nervous system (CNS), but its role therein is unclear because of a lack of suitable pharmacologic agents. Ideally, a chemical is required that crosses the blood-brain barrier, potently inhibits the adrenaline-synthesizing enzyme PNMT, and does not affect other catecholamine processes. Currently available PNMT inhibitors do not meet these criteria. We aim to produce potent, selective, and CNS-active PNMT inhibitors by structure-based design methods. The first step is the structure determination of PNMT. RESULTS: We have solved the crystal structure of human PNMT complexed with a cofactor product and a submicromolar inhibitor at a resolution of 2.4 A. The structure reveals a highly decorated methyltransferase fold, with an active site protected from solvent by an extensive cover formed from several discrete structural motifs. The structure of PNMT shows that the inhibitor interacts with the enzyme in a different mode from the (modeled) substrate noradrenaline. Specifically, the position and orientation of the amines is not equivalent. CONCLUSIONS: An unexpected finding is that the structure of PNMT provides independent evidence of both backward evolution and fold recruitment in the evolution of a complex enzyme from a simple fold. The proposed evolutionary pathway implies that adrenaline, the product of PNMT catalysis, is a relative newcomer in the catecholamine family. The PNMT structure reported here enables the design of potent and selective inhibitors with which to characterize the role of adrenaline in the CNS. Such chemical probes could potentially be useful as novel therapeutics.
+
The line below this paragraph, {{ABSTRACT_PUBMED_11591352}}, adds the Publication Abstract to the page
 +
(as it appears on PubMed at http://www.pubmed.gov), where 11591352 is the PubMed ID number.
 +
-->
 +
{{ABSTRACT_PUBMED_11591352}}
==Disease==
==Disease==
Line 34: Line 38:
[[Category: Methyltransferase]]
[[Category: Methyltransferase]]
[[Category: S-adenosyl methionine]]
[[Category: S-adenosyl methionine]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri May 2 19:02:48 2008''
+
 
 +
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Tue Jul 1 08:26:27 2008''

Revision as of 05:26, 1 July 2008

Image:1hnn.png

Template:STRUCTURE 1hnn

Contents

CRYSTAL STRUCTURE OF HUMAN PNMT COMPLEXED WITH SK&F 29661 AND ADOHCY(SAH)

Template:ABSTRACT PUBMED 11591352

Disease

Known disease associated with this structure: Hypertension, essential, 145500 (1) OMIM:[171190]

About this Structure

1HNN is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.

Reference

Getting the adrenaline going: crystal structure of the adrenaline-synthesizing enzyme PNMT., Martin JL, Begun J, McLeish MJ, Caine JM, Grunewald GL, Structure. 2001 Oct;9(10):977-85. PMID:11591352

Page seeded by OCA on Tue Jul 1 08:26:27 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/1hnn"
Personal tools